Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
September 30, 2016
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology
Marie von Lilienfeld-Toal, Annemarie Berger, Maximilian Christopeit, et al.
Annals of Hematology
|
April 13, 2021
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
Annika Y Classen, Larissa Henze, Marie von Lilienfeld-Toal, et al.
Pediatric Research
|
December 8, 2010
Prognosis factors in probands with an FBN1 mutation diagnosed before the age of 1 year
Chantal Stheneur, Laurence Faivre, Gwenaëlle Collod-Béroud, et al.
Human Mutation
|
December 14, 2011
Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex
Marianne Hoogeveen-Westerveld, Rosemary Ekong, Sue Povey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 23, 2022
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
Uwe Platzbecker, Katharina S Götze, Philipp Kiewe, et al.
Annals of Hematology
|
December 9, 2017
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Sibylle C Mellinghoff, Jens Panse, Nael Alakel, et al.
Blood Advances
|
September 16, 2021
Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy
Fabio Efficace, Uwe Platzbecker, Massimo Breccia, et al.
European Heart Journal
|
August 17, 2010
Cardiovascular manifestations in men and women carrying a FBN1 mutation
Delphine Détaint, Laurence Faivre, Gwenaelle Collod-Beroud, et al.
Blood
|
September 27, 2019
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
Frank G Rücker, Mridul Agrawal, Andrea Corbacioglu, et al.
Pediatrics
|
January 2, 2009
Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations
Laurence Faivre, Alice Masurel-Paulet, Gwenaëlle Collod-Béroud, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
European Journal of Cancer (Oxford, England : 1990)
|
September 30, 2016
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology
Marie von Lilienfeld-Toal, Annemarie Berger, Maximilian Christopeit, et al.
Annals of Hematology
|
April 13, 2021
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
Annika Y Classen, Larissa Henze, Marie von Lilienfeld-Toal, et al.
Pediatric Research
|
December 8, 2010
Prognosis factors in probands with an FBN1 mutation diagnosed before the age of 1 year
Chantal Stheneur, Laurence Faivre, Gwenaëlle Collod-Béroud, et al.
Human Mutation
|
December 14, 2011
Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex
Marianne Hoogeveen-Westerveld, Rosemary Ekong, Sue Povey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 23, 2022
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
Uwe Platzbecker, Katharina S Götze, Philipp Kiewe, et al.
Annals of Hematology
|
December 9, 2017
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Sibylle C Mellinghoff, Jens Panse, Nael Alakel, et al.
Blood Advances
|
September 16, 2021
Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy
Fabio Efficace, Uwe Platzbecker, Massimo Breccia, et al.
European Heart Journal
|
August 17, 2010
Cardiovascular manifestations in men and women carrying a FBN1 mutation
Delphine Détaint, Laurence Faivre, Gwenaelle Collod-Beroud, et al.
Blood
|
September 27, 2019
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
Frank G Rücker, Mridul Agrawal, Andrea Corbacioglu, et al.
Pediatrics
|
January 2, 2009
Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations
Laurence Faivre, Alice Masurel-Paulet, Gwenaëlle Collod-Béroud, et al.
Page
of 6